Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Kenmare Resources confident despite slide in revenue, earnings

(Sharecast News) - Titanium and zircon producer Kenmare Resources reported a 33% year-on-year decline in first-half revenue on Wednesday, to $154.5m. The London-listed firm attributed the drop to lower shipments, pricing, and an unfavourable product mix at its Moma Titanium Minerals Mine in northern Mozambique.

Despite the challenges, Kenmare said it ended the half-year with a record net cash position of $58.9m, after paying $34.7m in dividends and investing $49.1m in capital expenditure.

EBITDA fell 43% year-on-year to $63.2m, while profit after tax declined 69% to $20.9m.

Despite the downturn, Kenmare declared an interim dividend of 15 cents per share, adding that it expected the full-year dividend payout to be at the higher end of its 20% to 40% profit after tax target range.

Operationally, Kenmare achieved a 4% increase in both heavy mineral concentrate (HMC) and total finished product production, reaching 659,000 tonnes and 490,800 tonnes, respectively.

However, total shipments dropped by 14% due to poor weather and operational maintenance.

The company said it anticipated stronger performance in the second half of 2024, with increased shipments and a more favourable product mix, including the dispatch of two delayed zircon shipments.

Kenmare said it continued to make progress on sustainability initiatives, including reductions in greenhouse gas emissions and improvements in land rehabilitation and biodiversity.

The company also reported a lower lost time injury frequency rate (LTIFR) of 0.09 per 200,000 hours worked.

Corporate changes were also underway, as Michael Carvill stepped down as managing director, with Tom Hickey, the current finance director, set to succeed him.

Kenmare was also in the process of identifying a new chief financial officer.

The company said it remained on track to meet its 2024 guidance for ilmenite production, targeting 950,000 to 1,050,000 tonnes, supported by higher forecast grades in the second half of the year.

It was also advancing the upgrade of its wet concentrator plant (WCP) A, with 54% of the capital committed by the end of the first half, and 75% expected by year-end.

Constructive discussions with the Mozambican government regarding the renewal of Kenmare's implementation agreement for the Moma Mine's Industrial Free Zone were also ongoing.

"As previously announced, Michael Carvill, Kenmare's founder, today steps down as managing director after almost four decades," said chairman Andrew Webb.

"I would like to again express the board's appreciation and thanks to Michael, who leaves the Company with a robust balance sheet, strong and capable team, a tier one asset, a market-leading position and a robust balance sheet.

"Tom Hickey, Kenmare's finance director, has been appointed to succeed Michael."

Webb noted that Hickey had 24 years of experience as a public company director, with a "strong background" in finance, natural resources and African operations.

"Kenmare is on track to achieve 2024 guidance and in H1 we delivered an EBITDA margin of over 40%," he added, but noted that reduced shipments impacted the company's financial performance.

"Shipments have strengthened early in the second half, supported by strong visibility of customer orders, high finished product inventories and seasonally better weather conditions.

"Consequently, revenue is expected to be second-half weighted.

"With net current assets of almost $200m at the half year, including record net cash of $58.9m, we are well positioned to fund our capital commitments and shareholder returns."

At 1011 BST, shares in Kenmare Resources were up 2.45% at 335p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.
Loungers reports slight slowdown in LFL sales growth
(Sharecast News) - Cosy Club owner Loungers reported a slight slowdown in like-for-like sales growth on Tuesday and a jump in revenue.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.